1. Home
  2. OII vs LQDA Comparison

OII vs LQDA Comparison

Compare OII & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oceaneering International Inc.

OII

Oceaneering International Inc.

HOLD

Current Price

$23.30

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$33.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OII
LQDA
Founded
1964
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
OII
LQDA
Price
$23.30
$33.92
Analyst Decision
Hold
Strong Buy
Analyst Count
4
10
Target Price
$25.00
$37.40
AVG Volume (30 Days)
742.2K
1.5M
Earning Date
10-22-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
73.60
N/A
EPS
2.29
N/A
Revenue
$2,829,032,000.00
$69,216,000.00
Revenue This Year
$5.93
$904.79
Revenue Next Year
$0.78
$188.25
P/E Ratio
$10.50
N/A
Revenue Growth
8.71
343.41
52 Week Low
$15.46
$10.37
52 Week High
$28.31
$35.54

Technical Indicators

Market Signals
Indicator
OII
LQDA
Relative Strength Index (RSI) 36.81 60.40
Support Level $26.76 $32.11
Resistance Level $27.64 $35.40
Average True Range (ATR) 0.91 1.54
MACD -0.37 -0.16
Stochastic Oscillator 0.67 68.06

Price Performance

Historical Comparison
OII
LQDA

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: